What is the typical dose of promethazine (Phenergan) for sedation in an adult patient with no significant medical history and normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Promethazine Dosage for Sedation in Adults

For sedation in hospitalized adult patients, administer 25 to 50 mg of promethazine, with the FDA-approved dose being 25-50 mg for nighttime sedation. 1, 2

Route-Specific Dosing Recommendations

Intramuscular Administration (Preferred Route)

  • Deep intramuscular injection is the preferred parenteral route for promethazine due to significant tissue injury risks with other routes 1
  • Standard sedation dose: 25-50 mg IM 1
  • The deltoid muscle is the recommended injection site for adults 3

Intravenous Administration (Use with Caution)

  • If IV administration is necessary, use 25-50 mg infused slowly at ≤25 mg/minute to minimize hypotension risk 4, 1
  • Must be diluted to no greater than 25 mg/mL concentration 1
  • Preferably inject through functioning IV tubing rather than direct injection 1
  • Stop immediately if patient reports pain during injection to evaluate for arterial injection or extravasation 1

Oral Administration

  • 25-50 mg orally for nighttime sedation 2
  • Onset of action occurs within 20 minutes orally (versus 5 minutes IV) 5
  • Oral bioavailability is only 25%, though current dosing recommendations don't adjust for this 5, 6

Critical Timing and Duration Considerations

  • Onset of action: 5 minutes IV, 20 minutes PO 5
  • Duration of effect: 4-6 hours with effects potentially persisting up to 12 hours 4, 5
  • Plasma half-life is 9-16 hours 4, 5

Dose Reduction Strategies

Lower doses (12.5-25 mg) are equally effective for many indications while causing significantly less sedation:

  • The American Gastroenterological Association recommends 12.5-25 mg IV as the usual dose, with total doses of 25-100 mg when used as adjuvant to other sedatives 4, 5
  • Research demonstrates that 6.25-12.5 mg IV provides equivalent antiemetic efficacy to standard 25 mg doses with reduced sedation 6, 7
  • When combining with opioids or benzodiazepines, reduce promethazine dose as sedative effects are synergistic 4, 1, 2

Critical Safety Warnings

Absolute Contraindications

  • Never administer intra-arterially due to severe arteriospasm and gangrene risk 1
  • Subcutaneous injection is contraindicated due to tissue necrosis risk 1

Serious Adverse Effects to Monitor

  • Respiratory depression, particularly when combined with opioids or other CNS depressants 4, 5, 1
  • Hypotension, especially with rapid IV administration 4, 1
  • Extrapyramidal effects including neuroleptic malignant syndrome, dystonia, and oculogyric crises 4, 5
  • Tissue damage including thrombophlebitis, tissue necrosis, and gangrene with improper administration 5, 1

Common Pitfalls to Avoid

  • Avoid repeated or prolonged courses due to extrapyramidal effect risks and cumulative respiratory depression 5
  • Do not use for chronic sedation - promethazine is inappropriate for long-term use 5
  • When used with analgesics or barbiturates, reduce doses of concomitant medications accordingly 1, 2

Practical Algorithm for Sedation Dosing

  1. First-line approach: Administer 25 mg IM (deep deltoid injection) 3, 1
  2. If IV access already established: Give 12.5-25 mg IV slowly over at least 1 minute through functioning IV line 4, 1
  3. If combining with opioids/benzodiazepines: Start with 12.5 mg and reduce doses of other sedatives 4, 5
  4. May repeat dose within 2 hours if necessary, but transition to oral route as soon as feasible 1
  5. Maximum consideration: Total doses up to 25-100 mg may be used as adjuvant, but higher doses increase adverse effect risk 4

References

Guideline

Recommended Site for Intramuscular Promethazine Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Promethazine Prescription Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A comparison of two differing doses of promethazine for the treatment of postoperative nausea and vomiting.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.